Oracle Life Sciences has been recognized with two top honors from the 2025 Asia Pacific Biopharma Excellence Awards (ABEA). For the second year running, Oracle secured the Best Clinical Trials Supplier Award for Data Management & Analytics, showcasing its leadership in providing innovative data solutions for clinical research. In addition, Oracle received the Best Logistics & Supply Chain Management Supplier Award for Digital Technology & Software in recognition of its supply chain solutions for the biopharma industry.
The ABEA 2025, presented by leading biopharma intelligence firm IMAPAC, honors the region’s most innovative leaders, organizations, and technologies advancing biopharmaceutical manufacturing. The annual awards celebrate industry excellence and best practices.
“The recognition from Asia Pacific Biopharma Excellence Awards is a testament to the value our solutions deliver and the role they play in helping our customers get life-saving treatments to market faster,” said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. “We will continue to push the boundaries of innovation with AI and end-to-end analytics to deliver best-in-class clinical trial solutions that have a genuine impact on improving patient health and advancing the industry.”
Oracle continues to empower organizations to optimize clinical trials, advance patient-centric research, and enhance operational efficiencies throughout the drug development lifecycle. Oracle Life Sciences’ clinical trial data management solutions provide a validated, single source of truth for all clinical trial data that automatically reconciles data discrepancies and provides complete traceability throughout each phase of a study. In tandem, Oracle’s supply chain management solutions help organizations navigate contract manufacturing and complex global supply chains to get drugs and devices to patients faster.
